Deciphera Pharmaceuticals (DCPH) Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study
Go back to Deciphera Pharmaceuticals (DCPH) Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study(NASDAQ: DCPH) | Delayed: 14.18 -0.44 (3.01%) | |||||
---|---|---|---|---|---|---|
Previous Close | $14.62 | 52 Week High | $ | |||
Open | $14.43 | 52 Week Low | $ | |||
Day High | $14.85 | P/E | N/A | |||
Day Low | $14.00 | EPS | $ | |||
Volume | 527,033 |